These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9248638)

  • 1. Is there a need for antithrombin III substitution early after burn injury?
    Danielsson P; Nilsson L; Nettelblad H; Sjöberg F
    Burns; 1997 Jun; 23(4):300-5. PubMed ID: 9248638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Alteration in coagulation and fibrinolysis after burn injury and significance of anticoagulation therapy using heparin and antithrombin III concentrate].
    Ono I
    Hokkaido Igaku Zasshi; 1987 Jan; 62(1):108-21. PubMed ID: 3817736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticoagulation therapy for renal insufficiency after burns.
    Ono I; Ohura T; Azami K; Hoshi M; Hasegawa T
    Burns Incl Therm Inj; 1984 Dec; 11(2):104-10. PubMed ID: 6525533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of long-term and high-dose antithrombin supplementation on coagulation and fibrinolysis in patients with severe sepsis.
    Hoffmann JN; Mühlbayer D; Jochum M; Inthorn D
    Crit Care Med; 2004 Sep; 32(9):1851-9. PubMed ID: 15343012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in antithrombin III activity and other blood coagulation parameters after retinal detachment surgery.
    Malukiewicz-Wiśniewska G; Kotschy M
    Eur J Ophthalmol; 2000; 10(4):318-23. PubMed ID: 11192840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of antithrombin III (AT III) substitution to supranormal activities on systemic procoagulant turnover in patients with end-stage chronic liver disease.
    Scherer R; Kabatnik M; Erhard J; Peters J
    Intensive Care Med; 1997 Nov; 23(11):1150-8. PubMed ID: 9434921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Degree of hypercoagulability and hyperfibrinolysis is related to organ failure and prognosis after burn trauma.
    García-Avello A; Lorente JA; Cesar-Perez J; García-Frade LJ; Alvarado R; Arévalo JM; Navarro JL; Esteban A
    Thromb Res; 1998 Jan; 89(2):59-64. PubMed ID: 9630308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prethrombotic state in burn patients].
    Wang HL
    Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi; 1993 Nov; 9(6):441-6, 479. PubMed ID: 8149294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coagulation inhibitors in sepsis and disseminated intravascular coagulation.
    Lee WL; Downey GP
    Intensive Care Med; 2000 Nov; 26(11):1701-6. PubMed ID: 11193281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of antithrombin iii concentrations during cardiopulmonary surgery].
    Sonzogni V; Bellavita P; Carrara B; Cossolini M; Ferri F; Fabretti F; Mamprin F; Pelliccioli I
    Minerva Anestesiol; 2000; 66(1-2):17-23. PubMed ID: 10736978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antithrombin III in burned children].
    Del Principe D
    Minerva Anestesiol; 2003 May; 69(5):376-80. PubMed ID: 12768170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of disseminated intravascular coagulation with antithrombin III concentrate in children with verified infection].
    Nowak-Göttl U; Groll A; Kreuz WD; Brand M; Breddin HK; von Loewenich V; Kornhuber B
    Klin Padiatr; 1992; 204(3):134-40. PubMed ID: 1614177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombin (AT) substitution: sense or nonsense?
    Köhler M
    Anaesthesia; 1998 May; 53 Suppl 2():52-4. PubMed ID: 9659067
    [No Abstract]   [Full Text] [Related]  

  • 14. Changes in coagulation and fibrinolysis during laparoscopic cholecystectomy.
    Marakis G; Pavlidis TE; Ballas K; Karvounaris D; Rafailidis S; Sakantamis AK
    J Laparoendosc Adv Surg Tech A; 2006 Dec; 16(6):582-6. PubMed ID: 17243874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombin deficiency and its relationship to severe burns.
    Niedermayr M; Schramm W; Kamolz L; Andel D; Römer W; Hoerauf K; Zimpfer M; Andel H
    Burns; 2007 Mar; 33(2):173-8. PubMed ID: 17118562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinolysis, antithrombin III, and protein C in neonates during cardiac operations.
    Petăjă J; Peltola K; Sairanen H; Leijala M; Kekomäki R; Vahtera E; Siimes MA
    J Thorac Cardiovasc Surg; 1996 Sep; 112(3):665-71. PubMed ID: 8800154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antithrombin III concentrate use in patients with cirrhosis with coagulation disorders].
    Ribeiro AA; Lourenço DM; Toledo CF; Noguti MA; Borges DR
    Rev Assoc Med Bras (1992); 1997; 43(3):189-94. PubMed ID: 9497544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose antithrombin III treatment of severely injured patients: results of a prospective study.
    Waydhas C; Nast-Kolb D; Gippner-Steppert C; Trupka A; Pfundstein C; Schweiberer L; Jochum M
    J Trauma; 1998 Nov; 45(5):931-40. PubMed ID: 9820705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein C substitution in sepsis-associated purpura fulminans.
    Rintala E; Kauppila M; Seppälä OP; Voipio-Pulkki LM; Pettilä V; Rasi V; Kotilainen P
    Crit Care Med; 2000 Jul; 28(7):2373-8. PubMed ID: 10921567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombin III in hematopoietic stem cell transplantation.
    Haire WD
    Semin Thromb Hemost; 1997; 23(6):591-601. PubMed ID: 9469635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.